Human Immunology, Pathophysiology, Immunotherapy (HIPI) France

Research

Date range: 1 July 2021 - 30 June 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Human Immunology, Pathophysiology, Immunotherapy (HIPI) published between 1 July 2021 - 30 June 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Human Immunology, Pathophysiology, Immunotherapy (HIPI)
Count Share
8 0.97

Outputs by subject (Share)

Outputs by subject
Subject Count Share
8 0.97

Share output for the past 5 years

Share per year
2017 2018 2019 2020 2021
0.00 0.00 0.00 0.01 1.76

Compare Human Immunology, Pathophysiology, Immunotherapy (HIPI) with other institutions

Collaboration

Date range: 1 July 2021 - 30 June 2022

International vs. domestic collaboration by Share

  • 81.32% Domestic
  • 18.68% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Human Immunology, Pathophysiology, Immunotherapy (HIPI) by Share (67 total)

  1. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and University of Paris (2.24)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.97
    University of Paris1.27
  2. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and National Institute for Health and Medical Research (INSERM) (2.14)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.97
    National Institute for Health and Medical Research (INSERM)1.16
  3. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Assistance Publique-Hôpitaux de Paris (AP-HP) (1.79)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.90
    Assistance Publique-Hôpitaux de Paris (AP-HP)0.89
  4. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Université PSL (1.22)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.36
    Université PSL0.86
  5. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Sorbonne University (1.08)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.90
    Sorbonne University0.18
  6. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Immunity and Cancer Unit (1.04)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.09
    Immunity and Cancer Unit0.95
  7. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and French National Centre for Scientific Research (CNRS) (1.00)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.70
    French National Centre for Scientific Research (CNRS)0.30
  8. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Imagine Institute (0.93)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.33
    Imagine Institute0.60
  9. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Pasteur Institute (0.81)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.58
    Pasteur Institute0.23
  10. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and The French Alternative Energies and Atomic Energy Commission (CEA) (0.73)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.54
    The French Alternative Energies and Atomic Energy Commission (CEA)0.19

Top 10 international collaborators with Human Immunology, Pathophysiology, Immunotherapy (HIPI) by Share (28 total)

  1. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Harvard University (1.63)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.10
    Harvard University1.53
  2. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Ghent University (UGent) (0.40)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.20
    Ghent University (UGent)0.20
  3. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and F. Hoffmann-La Roche AG (0.34)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.31
    F. Hoffmann-La Roche AG0.03
  4. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and VIB-UGent Center for Inflammation Research (IRC) (0.33)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.20
    VIB-UGent Center for Inflammation Research (IRC)0.13
  5. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Flanders Institute for Biotechnology (VIB) (0.27)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.20
    Flanders Institute for Biotechnology (VIB)0.07
  6. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Metabolon Inc. (0.27)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.20
    Metabolon Inc.0.07
  7. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Ragon Institute of MGH, MIT and Harvard (0.26)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.08
    Ragon Institute of MGH, MIT and Harvard0.18
  8. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Massachusetts Institute of Technology (MIT) (0.21)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.08
    Massachusetts Institute of Technology (MIT)0.13
  9. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Broad Institute of MIT and Harvard (0.20)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.08
    Broad Institute of MIT and Harvard0.12
  10. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and City of Hope (0.17)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.07
    City of Hope0.10

Relationships

Partner Institutions

Human Immunology, Pathophysiology, Immunotherapy (HIPI) is a research collaboration whose article contributions are accrued to its participating partner institutions below.